You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 00536-1412


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00536-1412

Drug NameNDCPrice/Unit ($)UnitDate
ADAPALENE 0.1% GEL 00536-1412-26 0.37615 GM 2025-03-19
ADAPALENE 0.1% GEL 00536-1412-20 0.47617 GM 2025-03-19
ADAPALENE 0.1% GEL 00536-1412-26 0.37474 GM 2025-02-19
ADAPALENE 0.1% GEL 00536-1412-20 0.49608 GM 2025-02-19
ADAPALENE 0.1% GEL 00536-1412-26 0.37428 GM 2025-01-22
ADAPALENE 0.1% GEL 00536-1412-20 0.50856 GM 2025-01-22
ADAPALENE 0.1% GEL 00536-1412-26 0.37291 GM 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 00536-1412

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Understanding the National Drug Code (NDC) and Its Implications for Market Analysis and Price Projections

What is a National Drug Code (NDC)?

A National Drug Code (NDC) is a unique, 10-digit or 11-digit, 3-segment number that serves as a universal product identifier for human drugs in the United States. This code is crucial for identifying the labeler, the specific product, and the commercial package size of a drug[1][5].

Components of an NDC

  • Labeler Code: The first segment of the NDC identifies the labeler, which could be the drug manufacturer, repackager, or distributor.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug for a particular labeler.
  • Package Code: The third segment identifies the package sizes and types.

NDC Format and Proposed Changes

Currently, NDCs are in configurations such as 4-4-2, 5-3-2, or 5-4-1. However, the FDA has proposed a rule to adopt a single, uniform 12-digit format to address the issue of running out of 10-digit NDCs. This new format aims to minimize disruptions and ensure a consistent coding system[1].

Market Analysis for Drug NDC: 00536-1412

To conduct a market analysis for a specific drug identified by its NDC, such as 00536-1412, several factors need to be considered:

Drug Pricing Trends

Prescription drug prices in the U.S. have been significantly higher compared to other countries. Between 2017 and 2022, the average price per unit of prescription drugs in the U.S. increased by 14%, while prices in other parts of the world and the OECD (excluding the U.S.) decreased by 9% and 7%, respectively[4].

Recent Price Increases and Negotiations

Many drugs, especially those treating common conditions like cardiovascular disease, diabetes, and cancer, have seen substantial price increases. For example, nine out of ten drugs selected for the first year of Medicare's drug price negotiation program had list price increases ranging from 20% to 55% between 2018 and 2023[2].

Impact of Negotiations on Prices

Medicare's negotiations have resulted in significant discounts, ranging from 38% to 79% compared to list prices. This indicates that negotiated prices can substantially reduce the financial burden on patients and healthcare payers[2].

Price Projections for the Drug NDC: 00536-1412

Historical Pricing Data

To project future prices for the drug identified by NDC 00536-1412, historical pricing data is essential. This includes tracking the drug's list price changes over the years and comparing them to industry-wide trends.

Regulatory and Market Factors

  • FDA Negotiations and Regulations: Any changes in FDA regulations, such as the proposed 12-digit NDC format, could impact the drug's pricing and availability.
  • Market Competition: The presence of generic or biosimilar alternatives can influence the pricing strategy for the drug.
  • Economic Conditions: Economic factors such as inflation and healthcare policy changes can also affect drug prices.

Example of Price Impact

For instance, if the drug in question is one of those selected for Medicare's negotiation program, it could see a significant reduction in its list price. Here is an example based on the data provided:

  • List Price Increase: If the drug had a list price increase of 30% between 2018 and 2023, its price would have risen substantially.
  • Negotiated Price: If Medicare negotiations result in a 50% discount, the new price would be significantly lower than the current list price[2].

Role of AI and Data Trends in Pharma

AI Adoption in Pharma

The pharmaceutical industry is increasingly adopting artificial intelligence (AI) in various aspects, including clinical development and data analysis. AI can help in predicting price trends and optimizing pricing strategies by analyzing large datasets and market conditions[3].

External Data and AI Models

Pharmaceutical companies are turning to reliable external data to train their internal data science models. This trend is expected to grow, helping companies make more informed decisions about drug pricing and market strategies[3].

International Pricing Comparisons

U.S. vs. Global Prices

Prescription drug prices in the U.S. are significantly higher than in other countries. By 2022, prices in the U.S. were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world (excluding the U.S.)[4].

Implications for Market Analysis

Understanding these international pricing disparities is crucial for market analysis. Companies may need to adjust their pricing strategies based on regional market conditions and regulatory environments.

Key Takeaways

  • NDC Importance: The NDC is a critical identifier for drugs in the U.S., helping in tracking and pricing.
  • Pricing Trends: Recent years have seen significant price increases for many prescription drugs, with some exceptions.
  • Negotiations and Discounts: Medicare's negotiations have led to substantial discounts on list prices.
  • AI and Data Trends: AI adoption is increasing in the pharma industry, aiding in data analysis and pricing strategies.
  • International Pricing: U.S. drug prices are notably higher than in other countries.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique 10-digit or 11-digit, 3-segment number that identifies the labeler, product, and commercial package size of a drug in the United States.

How are NDCs structured?

NDCs are structured into three segments: the labeler code, the product code, and the package code. The configurations can be 4-4-2, 5-3-2, or 5-4-1.

What is the impact of Medicare's drug price negotiations on prices?

Medicare's negotiations have resulted in discounts ranging from 38% to 79% compared to list prices, making prescription drugs more affordable for Medicare enrollees.

How does AI influence drug pricing strategies?

AI helps pharmaceutical companies analyze large datasets and market conditions, enabling them to make more informed decisions about drug pricing and market strategies.

Why are U.S. drug prices higher than in other countries?

U.S. drug prices are higher due to various factors, including regulatory environments, market conditions, and the drug mix, which skews towards more expensive compounds.

Sources

  1. Drugs.com: National Drug Codes Explained: What You Need to Know
  2. ASPE - HHS.gov: Medicare Drug Price Negotiation Program
  3. Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
  4. ASPE - HHS.gov: International Market Size and Prices
  5. FDA.gov: National Drug Code Database Background Information

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.